Bruce C. Cozadd
Chairman & CEO at Jazz Pharmaceuticals plc
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Jazz Pharmaceuticals plc, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Jazz Pharmaceuticals plc July 23, 202696.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 5, 2026 | Jazz Pharmaceuticals plc | Grant or award | +1,605 | — | — |
| Aug 3, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $252.98 | $1,517,880 |
| Jul 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $240.47 | $1,442,820 |
| Jun 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $235.12 | $1,410,720 |
| May 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $203.33 | $1,219,980 |
| Apr 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −3,684 | $190.22 | $700,770 |
| Apr 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −2,292 | $190.94 | $437,634 |
| Apr 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −24 | $191.74 | $4,602 |
| Mar 5, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −15,114 | $188.69 | $2,851,861 |
| Mar 3, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −3,159 | $186.09 | $587,858 |
| Mar 3, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −2,608 | $186.73 | $486,992 |
| Mar 3, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −233 | $187.84 | $43,767 |
| Jan 16, 2026 | Jazz Pharmaceuticals plc | Grant or award | +35,917 | — | — |
| Jan 16, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −17,453 | $171.16 | $2,987,255 |
| Nov 26, 2025 | Jazz Pharmaceuticals plc | Option exercise | +76,689 | $123.36 | $9,460,355 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.